Recall archive / FDA company announcement

Golden State Medical Supply, Incorporated: Clopidogrel 75mg Tablets, Atenolol 25mg Tablets — FDA announcement Sep 29, 2022

Reported terminated

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Sep 29, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product: Clopidogrel 75mg Tablets, Atenolol 25mg Tablets
Reason: Due to Label Mix-up
Classification: Not supplied
Recalling firm: Golden State Medical Supply, Incorporated
Quantity: Not supplied
Agency-reported status: Terminated in FDA listing
Source record identifier: cb3d042728bd362c

Open the official record

Lot and product identifiers

Label field	Details supplied by the agency
Lot, code or applicability	FOR IMMEDIATE RELEASE- SEPTEMBER 29, 2022, Golden State Medical Supply, Incorporated (GSMS, Inc.) - Camarillo, CA has initiated a voluntary recall of the products listed in the table below because a report was received that a bottle containing Clopidogrel 75mg Tablets produced with lot# GS046745 was mislabeled as Atenolol 25mg Tablets. This voluntary recall only affects products with lot# GS046745. No other Clopidogrel or Atenolol products marketed by GSMS, Inc. are impacted. Both products are being recalled out of abundance of caution.; The lot under GSMS, Inc.’s voluntary recall has been primarily sold to AmerisourceBergen, and McKesson. AmerisourceBergen and McKesson are instructed to immediately stop distribution, quarantine all remaining products in their control, and return the recalled product to GSMS, Inc. They are also instructed to provide their customers, i.e., pharmacies and consumers, a copy of GSMS, Inc.’s recall notification, recall response form, and letter to consumers, patients, and caregivers.; Product Description \| GSMS NDC \| Lot # \| Expiration Date; Clopidogrel 75mg Tablets, 1,000 Count Bottle \| 51407-032-10 \| GS046745 \| 12/2023; Atenolol 25mg Tablets, 1,000 Count Bottle \| 60429-027-10 \| GS046745 \| 12/2023

Label field

Details supplied by the agency

Lot, code or applicability

FOR IMMEDIATE RELEASE- SEPTEMBER 29, 2022, Golden State Medical Supply, Incorporated (GSMS, Inc.) - Camarillo, CA has initiated a voluntary recall of the products listed in the table below because a report was received that a bottle containing Clopidogrel 75mg Tablets produced with lot# GS046745 was mislabeled as Atenolol 25mg Tablets. This voluntary recall only affects products with lot# GS046745. No other Clopidogrel or Atenolol products marketed by GSMS, Inc. are impacted. Both products are being recalled out of abundance of caution.; The lot under GSMS, Inc.’s voluntary recall has been primarily sold to AmerisourceBergen, and McKesson. AmerisourceBergen and McKesson are instructed to immediately stop distribution, quarantine all remaining products in their control, and return the recalled product to GSMS, Inc. They are also instructed to provide their customers, i.e., pharmacies and consumers, a copy of GSMS, Inc.’s recall notification, recall response form, and letter to consumers, patients, and caregivers.; Product Description | GSMS NDC | Lot # | Expiration Date; Clopidogrel 75mg Tablets, 1,000 Count Bottle | 51407-032-10 | GS046745 | 12/2023; Atenolol 25mg Tablets, 1,000 Count Bottle | 60429-027-10 | GS046745 | 12/2023

Match all identifying details in the current notice. A brand name alone is not enough.

Product tables from the announcement

These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.

FDA company announcement, table 1
Product Description	GSMS NDC	Lot #	Expiration Date
Clopidogrel 75mg Tablets, 1,000 Count Bottle	51407-032-10	GS046745	12/2023
Atenolol 25mg Tablets, 1,000 Count Bottle	60429-027-10	GS046745	12/2023

Announcement retrieved Oct 1, 2026. Official announcement.

Distribution

Not supplied

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Fda listing date: Sep 29, 2022
Company announcement date: Sep 29, 2022

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.